An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method

PHASE4CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

August 31, 2003

Conditions
Female Contraception
Interventions
DRUG

norelgestromin; ethinyl estradiol

All Listed Sponsors
lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00653016 - An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method | Biotech Hunter | Biotech Hunter